Reduced level of 25-hydroxyvitamin D in chronic/relapsing Alopecia Areata.

Roberto d'Ovidio, Margherita Vessio, Francesco Domenico d'Ovidio

Other Dermato-endocrinology 2013 62 atıf

<\/script>\n

`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D24194967'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

Çalışma Türü: Observational Study
Popülasyon: Patients with chronic/relapsing alopecia areata

Müdahale: Reduced level of 25-hydroxyvitamin D in chronic/relapsing Alopecia Areata. None
Karşılaştırıcı: None
Birincil Sonuç: 25-hydroxyvitamin D levels in alopecia areata patients
Etki Yönü: Negative
Yanlılık Riski: Unclear

Abstract

Current observations link vitamin D deficiency to many autoimmune diseases. There are limited data on vitamin D in Alopecia Areata, an autoimmune disease which in our experience shows seasonality in most of its remitting-relapsing forms. Our results demonstrate the presence of insufficiency of 25-hydroxyvitamin D (25OH-D) in many patients with various clinical forms, correlated with the expected increase of the values of Parathyroid Hormone (PTH). This could suggest the possible clinical use of vitamin D in the management of this frustrating disease.

Kısaca

The results demonstrate the presence of insufficiency of 25-hydroxyvitamin D in many patients with various clinical forms, correlated with the expected increase of the values of Parathyroid Hormone (PTH), which could suggest the possible clinical use of vitamin D in the management of this frustrating disease.

Used In Evidence Reviews

A Vitamin D için Autoimmune Conditions

B Vitamin D için Immune Aging (Immunosenescence)

Reduced level of 25-hydroxyvitamin D in chronic/relapsing Alopecia Areata.

Embed This Widget

Study Design

Abstract

Kısaca

Used In Evidence Reviews

Similar Papers

Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey.

Systemic lupus erythematosus: Diagnosis and clinical management.

Vitamin D and the immune system.

Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections.

Primary prevention of colorectal cancer.

Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers.